-
1.
[Autonomous Neurology within the University Hospital of LMU at 50 years].
Danek, A, König, N, Brandt, T, Dieterich, M
MMW Fortschritte der Medizin. 2022;(Suppl 7):23-31
Abstract
Establishment of the Chair of Neurology at the University of Munich in 1971 as well as the opening of the Neurology Department at the newly built Großhadern campus (1974) provide an occasion to review the 50 years that have passed since. Further, the early history of Munich neurology is described, with its slow pace of separation (in comparison to e.g. Heidelberg, Frankfurt and Hamburg) from the parent disciplines, psychiatry and internal medicine. In Munich, they were long shaped by psychiatrists such as Bernhard von Gudden, Emil Kraepelin, Kurt Kolle and Hanns Hippius and by Friedrich von Müller and, in particular, by Gustav Bodechtel in internal medicine.Once independent, further development of neurology in Munich was characterized by fast-paced, almost revolutionary changes in neuroimaging, electrophysiology, sonography, and engineering as well as in basic neuroscience, neurogenetics included. The new department thrived under the leadership of Adolf Schrader (from 1971), Thomas Brandt (from 1984) and Marianne Dieterich (from 2008) who enjoyed the support of an ever-increasing specialised clinical-scientific staff.Evidence-based treatment of neurological disorders became the overarching and internationally visible focus of Munich neurology, with respect to both practical implementation and to research. The exemplary diseases and syndromes of multiple sclerosis, epilepsy, stroke, movement disorders, dizziness and disorders of balance and gait as well as diseases of the musculature and peripheral nerves are cared for not only within the inpatient and outpatient sections of the Neurology Department but also by units such as the Friedrich Baur Institute (FBI), the German Dizziness and Balance Centre (DSGZ), the Institutes for Stroke and Dementia Research (ISD) and for Clinical Neuroimmunology as well as in the interdisciplinary Department of Palliative Care.
-
2.
Professor Ernesto Carafoli: a Personal Appreciation.
Mikoshiba, K
Biochemical and biophysical research communications. 2022;:9-12
-
3.
What Is Addiction? History, Terminology, and Core Concepts.
Olsen, Y
The Medical clinics of North America. 2022;(1):1-12
Abstract
Medicine's acceptance of addiction as a medical concept has waxed and waned over time. Addiction, as a disease, fits with modern disease definitions and scientific advances in elucidating the interactions between neurobiology and environment. Definitions of addiction need to acknowledge the complex interactions of brain circuits, genetics, environmental factors, and individual life experiences. Addiction aligns with diagnostic categories of substance use disorders that do not rely on tolerance and withdrawal as defining characteristics. Shifts in social and political views of addiction continue to propel and mirror changes in addiction treatment approaches and terminology within the medical community.
-
4.
[History of Ketamine: An ancient molecule that is still popular today].
Le Daré, B, Pelletier, R, Morel, I, Gicquel, T
Annales pharmaceutiques francaises. 2022;(1):1-8
-
-
Free full text
-
Abstract
The history of ketamine begins in 1962, when Calvin Stevens of the pharmaceutical laboratory Parke-Davis synthesizes it from phencyclidine, a molecule with psychodysleptic, hallucinogenic and dissociative properties. Following the first administration of ketamine to humans in 1964 in Jackson prison (Michigan, USA), its dissociative effects associated with short anaesthesia were reported, and a patent for its human use was filed in 1966. In the 1990s, the discovery of opioid-induced hyperalgesia sparked interest in ketamine as an analgesic. In recent years, the human use of ketamine, and in particular its esketamine enantiomer, has shifted towards the treatment of depression. The first cases of ketamine abuse were reported in 1992 in France, leading to special surveillance by the health authorities, and its inclusion in the list of narcotic drugs in 1997. Today, ketamine has become an attractive substance for recreational use, gradually emerging from alternative techno circles to spread to more commercial party scenes. These elements represent a public health concern, associated with the risk of developing new chemically synthesized analogues, the harmful effects of which are still little known.
-
5.
Food for the soul and food for the body. Studying dietary patterns and funerary meals in the Western Roman Empire: An anthropological and archaeozoological approach.
Salazar-García, DC, Colominas, L, Jordana, X
PloS one. 2022;(8):e0271296
Abstract
Ancient written sources show that Roman funerary rituals were relevant along the entire Roman Republic and Empire, as they ensured the protection of deities and the memory of the deceased. Part of these rituals consisted of funerary offerings and banquets that were held on the day of the burial, in festivities and other stipulated days. The faunal remains recovered inside the graves and around them are evidence of these rituals. Therefore, their study can allow us to know if the funerary meals and rituals developed in the Roman necropolis were special and implied food that differed from everyday dietary habits, according to the importance of these rituals. To test this, we analysed the archaeozoological and anthropological material from the necropolis of Vila de Madrid (Barcelona, Catalonia), which was in use between the first half of the 2nd century AD and mid 3rd century AD. The archaeozoological analysis of the faunal remains recovered in the necropolis and inside the graves, as well as carbon and nitrogen stable isotope ratios results on bone collagen from 50 faunal specimens and 41 humans, suggest that, overall, funerary meals in Vila de Madrid necropolis did not imply different food than that consumed during life. Regarding age, sex, offerings and diet, some differences are observed, suggesting that inequalities present in life could have been also present in the funerary rituals.
-
6.
Ancient DNA at the edge of the world: Continental immigration and the persistence of Neolithic male lineages in Bronze Age Orkney.
Dulias, K, Foody, MGB, Justeau, P, Silva, M, Martiniano, R, Oteo-García, G, Fichera, A, Rodrigues, S, Gandini, F, Meynert, A, et al
Proceedings of the National Academy of Sciences of the United States of America. 2022;(8)
Abstract
Orkney was a major cultural center during the Neolithic, 3800 to 2500 BC. Farming flourished, permanent stone settlements and chambered tombs were constructed, and long-range contacts were sustained. From ∼3200 BC, the number, density, and extravagance of settlements increased, and new ceremonial monuments and ceramic styles, possibly originating in Orkney, spread across Britain and Ireland. By ∼2800 BC, this phenomenon was waning, although Neolithic traditions persisted to at least 2500 BC. Unlike elsewhere in Britain, there is little material evidence to suggest a Beaker presence, suggesting that Orkney may have developed along an insular trajectory during the second millennium BC. We tested this by comparing new genomic evidence from 22 Bronze Age and 3 Iron Age burials in northwest Orkney with Neolithic burials from across the archipelago. We identified signals of inward migration on a scale unsuspected from the archaeological record: As elsewhere in Bronze Age Britain, much of the population displayed significant genome-wide ancestry deriving ultimately from the Pontic-Caspian Steppe. However, uniquely in northern and central Europe, most of the male lineages were inherited from the local Neolithic. This suggests that some male descendants of Neolithic Orkney may have remained distinct well into the Bronze Age, although there are signs that this had dwindled by the Iron Age. Furthermore, although the majority of mitochondrial DNA lineages evidently arrived afresh with the Bronze Age, we also find evidence for continuity in the female line of descent from Mesolithic Britain into the Bronze Age and even to the present day.
-
7.
Emerging signals of declining forest resilience under climate change.
Forzieri, G, Dakos, V, McDowell, NG, Ramdane, A, Cescatti, A
Nature. 2022;(7923):534-539
-
-
Free full text
-
Abstract
Forest ecosystems depend on their capacity to withstand and recover from natural and anthropogenic perturbations (that is, their resilience)1. Experimental evidence of sudden increases in tree mortality is raising concerns about variation in forest resilience2, yet little is known about how it is evolving in response to climate change. Here we integrate satellite-based vegetation indices with machine learning to show how forest resilience, quantified in terms of critical slowing down indicators3-5, has changed during the period 2000-2020. We show that tropical, arid and temperate forests are experiencing a significant decline in resilience, probably related to increased water limitations and climate variability. By contrast, boreal forests show divergent local patterns with an average increasing trend in resilience, probably benefiting from warming and CO2 fertilization, which may outweigh the adverse effects of climate change. These patterns emerge consistently in both managed and intact forests, corroborating the existence of common large-scale climate drivers. Reductions in resilience are statistically linked to abrupt declines in forest primary productivity, occurring in response to slow drifting towards a critical resilience threshold. Approximately 23% of intact undisturbed forests, corresponding to 3.32 Pg C of gross primary productivity, have already reached a critical threshold and are experiencing a further degradation in resilience. Together, these signals reveal a widespread decline in the capacity of forests to withstand perturbation that should be accounted for in the design of land-based mitigation and adaptation plans.
-
8.
Vitamin C and scar strength: analysis of a historical trial and implications for collagen-related pathologies.
Hujoel, PP, Hujoel, MLA
The American journal of clinical nutrition. 2022;(1):8-17
-
-
Free full text
-
Abstract
A double-blind controlled trial initiated in 1944 has led to the common narrative that a 10-mg daily vitamin C intake is adequate to prevent and treat impaired wound healing, and by inference, other collagen-related diseases such as heart disease or stroke. The WHO relies on this narrative to set the recommended nutrient intake for vitamin C. This narrative, however, is based on what is known as the eyeball method of data assessment. The 1944 trial published individual participant data on scar strength providing an opportunity to statistically probe the validity of the 10-mg narrative, something which has not yet been done. The findings show that a vitamin C intake that averages to 10 mg/d over a mean follow-up of 11.5 mo was associated with a 42% weakened scar strength when compared with 80 mg vitamin C intake/d (P < 0.001). The observed dose-response curve between scar strength and vitamin C intake suggests that the daily vitamin C intake needed to prevent collagen-related pathologies is in the range recommended by the National Academy of Medicine and the European Food Safety Authority (75 to 110 mg/d), not the WHO recommendation (45 mg/d). The findings also show that a vitamin C intake that averages to 65 mg/d over a mean follow-up of 6.5 mo failed to restore the normal wound-healing capacity of vitamin C-depleted tissues; such tissues had a 49% weaker scar strength when compared with nondepleted tissues (P < 0.05). Thus, average daily vitamin C intakes ∼50% higher than the WHO recommends may fail to treat existing collagen-related pathologies. It is concluded that the prior lack of statistical analyses of a landmark trial may have led to a misleading narrative on the vitamin C needs for the prevention and treatment of collagen-related pathologies.
-
9.
Celebrating the Professional Life of Professor Kevin D. Tipton (1961-2022).
Witard, OC, Ferrando, AA, Phillips, SM
International journal of sport nutrition and exercise metabolism. 2022;(3):129-132
Abstract
This invited editorial celebrates the distinguished professional life of Professor Kevin D. Tipton, who sadly passed away on January 9, 2022. Professor Tipton made an outstanding contribution to the scientific field of sport nutrition and exercise metabolism over an exceptional 30-year career. He dedicated his academic career to understanding the response of muscle protein metabolism to exercise and nutrition. The impact of his work is far-reaching with application to athletes in terms of promoting training adaptation, recovery, and performance, alongside clinical implications for injury management and healthy aging. Notable scientific contributions included the first in vivo human study to demonstrate the role of orally ingested essential amino acids in stimulating muscle protein synthesis during acute post-exercise recovery. This finding laid the foundation for future studies to interrogate the response of muscle protein synthesis to the ingestion of different protein types. Professor Tipton's work also included investigating the maximally effective dose and timing (regarding exercise) of ingested protein for the stimulation of muscle protein synthesis. Kevin will be remembered fondly by academics, applied scientists, and students across the sport nutrition and exercise metabolism community as a leading researcher in the field, a critical thinker, and an inspirational teacher. His mission was to educate the next generation of exercise scientists by sharing his distinct wealth of knowledge accrued over three decades. Above all else, Kevin was kind, generous (with his time and knowledge), honest, and incredibly social. He was a unique character and will be greatly missed among our community but certainly never forgotten.
-
10.
Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
Stefano, GB
Medical science monitor : international medical journal of experimental and clinical research. 2021;27:e931447
-
-
-
Free full text
Plain language summary
Literature shows that there are long-term symptoms and organ damage in patients with confirmed coronavirus disease 2019 (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 that persist after the acute illness. The aim of this review was to present a historical overview of infections and disorders associated with the neurological and psychiatric sequelae that have shown similarities with long COVID. Historically, the common symptom of altered cognition has been reported during earlier pandemics. Pandemics discussed in this review include; influenza pandemics of 1889 and 1892 (Russian flu), Spanish flu pandemic (1918-1919), encephalitis lethargica, diphtheria, and myalgic encephalomyelitis (chronic fatigue syndrome or post-viral fatigue syndrome). Furthermore, literature shows that there are similarities between the symptoms of chronic fatigue syndrome and the brain fog of long COVID. Viral infection, cerebral hypoxia [reduced supply of oxygen to the brain), cognitive dysfunction, or brain fog may occur along a common pathway in the long-term pathogenesis of epidemic and pandemic infections, including COVID-19. Authors conclude that utilising data from past epidemics and pandemics may help to identify common acute and chronic syndromes, including neurological and psychiatric sequelae with similarities to the conditions currently described in patients with long COVID.
Abstract
Long-term sequelae of coronavirus disease 2019 (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now recognized. However, there is still a lack of consensus regarding the terminology for this emerging chronic clinical syndrome, which includes long COVID, chronic COVID syndrome, post-COVID-19 syndrome, post-acute COVID-19, and long-hauler COVID-19. In this review, I will use the term "long COVID". A review of the medical history and epidemiology of past pandemics and epidemics in modern literature review identifies common long-term post-infectious disorders, with the common finding of altered cognition. In the brain, the cerebral hypoxia induced by SARS-CoV-2 infection may be caused by mitochondrial dysfunction, resulting in "brain fog". Historically, the common symptom of altered cognition has been reported during earlier pandemics, which include the influenza pandemics of 1889 and 1892 (Russian flu), the Spanish flu pandemic (1918-1919), encephalitis lethargica, diphtheria, and myalgic encephalomyelitis (chronic fatigue syndrome or post-viral fatigue syndrome). There are similarities between chronic fatigue syndrome and the "brain fog" described in long COVID. During past viral epidemics and pandemics, a commonality of neural targets may have increased viral survival by conformational matching. The neurological and psychiatric sequelae of SARS-CoV-2 infection, or long COVID, may have emerged from neural effects that have emerged from an invertebrate and vertebrate virosphere. This review aims to present a historical overview of infections and disorders associated with neurological and psychiatric sequelae that have shown similarities with long COVID.